Search results
Results from the WOW.Com Content Network
Karen S. Lynch (née Rohan, born December 30, 1963) is an American businesswoman and the former president and chief executive officer (CEO) of CVS Health. Lynch is on the board of directors of AHIP and previously CVS Health and U.S. Bancorp. In 2015, she became the first female president of Aetna.
He first worked at Aetna before joining CVS Caremark, eventually becoming president of the company. [1] He briefly left CVS and returned to run Caremark. [5] He is on the advisory council of the Rawls College of Business. [1] In October 2024, Joyner became the president and chief executive officer of CVS Health, along with joining the board of ...
John Rowe, chief executive officer of Aetna from 2000 to 2006 [27] V. J. Skutt , president and chief executive officer of Mutual of Omaha until 1984, [ 28 ] later named chairman emeritus [ 29 ] Brian Thompson , chief executive office of UnitedHealthcare from 2021 until his killing in 2024 [ 30 ]
In August, rising costs at CVS’ insurance arm Aetna cut into profits, leading to the ousting of then-president Brian Kane. ... Lynch had served as CEO since 2021 and led the company through the ...
Karen Lynch, a superstar CEO championing the biggest of big ideas, is out. As chief of corner drugstore and health insurance colossus CVS, Lynch headed the largest Fortune 500 enterprise, measured ...
CVS CEO Karen Lynch lost her job in a surprise ouster on Friday. ... That transition started with CVS's 2018 $68 billion acquisition of Aetna, which is how former Aetna president Lynch got to the ...
Merlo announced his retirement from CVS on November 6, 2020 with January 31, 2021 being his last day. He was succeeded by Karen S. Lynch, then Executive Vice President, CVS Health and President, Aetna at the time. [10] Over the course of his tenure, CVS stock rose from $33.21 to $72.08, a 217% gain in share price. Comparatively, the S&P 500 ...
Good morning. CVS Health has abruptly appointed a new CEO as its stock performance has sagged amid a rise in medical costs. The company, No. 6 on the Fortune 500, announced on Friday that Karen ...